Berberine and alkaloids research
Berberine and alkaloids research is a research topic within Pharmacology. Science Explorer counts 9.8k research works in it since 1950. 22.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the therapeutic potential of berberine alkaloids, particularly in the context of metabolic disorders such as diabetes mellitus. The research covers various aspects including the mechanisms of action, anti-inflammatory effects, cholesterol-lowering properties, and potential anticancer activities. Additionally, it explores the traditional use of berberine in Chinese medicine and its impact on glucose metabolism.
- Berberine
- Alkaloids
- Metabolic Effects
- Diabetes Mellitus
- Anti-inflammatory
- AMP-Activated Protein Kinase
- Cholesterol-lowering
- Anticancer
- Glucose Metabolism
- Traditional Medicine
- Research works
- 9.8k fractional, since 1950
- In the world top 10%
- 2.2k per year above
- Top-10% rate
- 22.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +36% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Berberine and alkaloids research research?
By volume, China and India publish the most (1k and 249 works in 2022–2025).
By volume, 2022–2025
- 1 China 1k works
- 2 India 249 works
- 3 United States 132 works
- 4 Iran 100 works
- 5 Türkiye 43 works
- 6 Egypt 40 works
- 7 South Korea 38 works
- 8 Pakistan 36 works
- 9 Saudi Arabia 35 works
- 10 Japan 35 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Berberine and alkaloids research research?
By volume in 2022–2025, Chengdu University of Traditional Chinese Medicine publishes the most Berberine and alkaloids research research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and China Pharmaceutical University.
By volume, 2022–2025
- 1 Chengdu University of Traditional Chinese MedicineChina 37 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 29 works
- 3 China Pharmaceutical UniversityChina 18 works
- 4 Guangzhou University of Chinese MedicineChina 17 works
- 5 Nanjing University of Chinese MedicineChina 17 works
- 6 Shanghai University of Traditional Chinese MedicineChina 17 works
- 7 Tianjin University of Traditional Chinese MedicineChina 16 works
- 8 Beijing University of Chinese MedicineChina 16 works
- 9 Zhejiang Chinese Medical UniversityChina 13 works
- 10 Shenyang Pharmaceutical UniversityChina 10 works
Who are the leading researchers in Berberine and alkaloids research?
The most-cited researchers publishing on Berberine and alkaloids research include Robert Verpoorte.
- 1 Robert Verpoorte Netherlands 1.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Berberine and alkaloids research research done?
The largest centres of Berberine and alkaloids research research in 2022–2025 are Beijing (China), Chengdu (China), Guangzhou (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Kunming and Chengdu.
Largest cities, 2022–2025
Where it is the local speciality
- KunmingCN · 23.6 works5.3×
- ChengduCN · 65.3 works4.5×
Location quotient: how much more of its research is in Berberine and alkaloids research than the world average.
Where is the best place to study Berberine and alkaloids research?
Among universities, judged by research, Chengdu University of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College and Guangzhou University of Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chengdu University of Traditional Chinese MedicineChina | 81.9 | 46.2% | 77.6× | 37 | +10.2% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 81.6 | 45.5% | 14.2× | 29 | -4.6% |
| 3 | Guangzhou University of Chinese MedicineChina | 79.5 | 43.2% | 44.0× | 18 | +75.3% |
| 4 | Beijing University of Chinese MedicineChina | 73.8 | 39.1% | 43.7× | 16 | +82.0% |
| 5 | China Pharmaceutical UniversityChina | 61.8 | 34.4% | 38.3× | 18 | +4.4% |
| 6 | Zhejiang Chinese Medical UniversityChina | 59.8 | 36.1% | 24.0× | 13 | +22.7% |
| 7 | Nanjing University of Chinese MedicineChina | 58.1 | 36.6% | 32.3× | 17 | -28.9% |
| 8 | Tianjin University of Traditional Chinese MedicineChina | 55.7 | 31.0% | 77.2× | 16 | +6.2% |
| 9 | Shandong University of Traditional Chinese MedicineChina | 53.0 | 43.3% | 31.2× | 8 | -39.8% |
| 10 | Heilongjiang University of Chinese MedicineChina | 52.3 | 38.8% | 69.8× | 10 | -21.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Berberine and alkaloids research research growing?
Output in 2018–2022 was 36% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Berberine and alkaloids research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.